AmpliPhi Biosciences Corporation

Release Summary

Renowned Sinus Surgeon Dr. Peter-John Wormald Comments on AmpliPhi Biosciences’ Favorable Phase 1 Results of AB-SA01 in Chronic Rhinosinusitis Patients

AmpliPhi Biosciences Corporation